1. Home
  2. BCAL vs SANA Comparison

BCAL vs SANA Comparison

Compare BCAL & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern California Bancorp

BCAL

Southern California Bancorp

N/A

Current Price

$21.13

Market Cap

699.7M

Sector

Finance

ML Signal

N/A

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

N/A

Current Price

$1.75

Market Cap

605.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BCAL
SANA
Founded
2001
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
699.7M
605.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
BCAL
SANA
Price
$21.13
$1.75
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
★ $24.75
$8.43
AVG Volume (30 Days)
154.2K
★ 2.4M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 2.24%
N/A
EPS Growth
★ 777.27
17.24
EPS
★ 1.30
N/A
Revenue
N/A
N/A
Revenue This Year
$1.29
N/A
Revenue Next Year
$6.46
N/A
P/E Ratio
$16.53
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.87
$1.84
52 Week High
$22.59
$5.49

Technical Indicators

Market Signals
Indicator
BCAL
SANA
Relative Strength Index (RSI) 38.56 26.34
Support Level $20.60 N/A
Resistance Level $22.00 $3.41
Average True Range (ATR) 0.50 0.18
MACD -0.08 -0.05
Stochastic Oscillator 18.42 0.00

Price Performance

Historical Comparison
BCAL
SANA

About BCAL Southern California Bancorp

California BanCorp is a relationship-focused community bank offering commercial loan and deposit products, along with other services delivered directly or through strategic alliances, to business and individual customers in its target markets. The Company provides financial products and services to individuals, professionals, and small to medium-sized businesses through its branch and commercial banking offices serving California. Its lending products consist mainly of construction and land development loans, real estate loans, C&I loans, and consumer loans, and it is a Preferred SBA Lender, while its deposit products consist mainly of demand deposit, money market, and certificates of deposit. The Company operates in one reportable segment, commercial banking.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Share on Social Networks: